RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits

Neuron

Volumn 73, Issue 2, 2012, Pages 347-359

  Lerner, TaliaN ^a   Kreitzer, AnatolC ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; CALCIUM; CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 2 RECEPTOR; ENDOCANNABINOID; PHOSPHOLIPASE C BETA; PHOSPHOLIPASE D; PROTEIN TYROSINE KINASE; RGS4 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; DOPAMINERGIC TRANSMISSION; LONG TERM DEPRESSION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CORPUS STRIATUM; DOPAMINE; ENDOCANNABINOIDS; LONG-TERM SYNAPTIC DEPRESSION; MICE; NEURONS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PHOSPHOLIPASE D; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RGS PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84856304569     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.11.015     Document Type: Article

References (63)

1. Ade K.K., Lovinger D.M. Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. J.Neurosci. 2007, 27:2403-2409.
2. Adermark L., Lovinger D.M. Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. J.Neurosci. 2007, 27:6781-6787.
3. Ahn K., McKinney M.K., Cravatt B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 2008, 108:1687-1707.
4. Bence-Hanulec K.K., Marshall J., Blair L.A. Potentiation of neuronal L calcium channels by IGF-1 requires phosphorylation of the alpha1 subunit on a specific tyrosine residue. Neuron 2000, 27:121-131.
5. Bence K., Ma W., Kozasa T., Huang X.Y. Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit. Nature 1997, 389:296-299.
6. Blazer L.L., Roman D.L., Chung A., Larsen M.J., Greedy B.M., Husbands S.M., Neubig R.R. Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Mol. Pharmacol. 2010, 78:524-533.
7. Blazer L.L., Zhang H., Casey E.M., Husbands S.M., Neubig R.R. A nanomolar-potency small molecule inhibitor of regulator of G-protein signaling proteins. Biochemistry 2011, 50:3181-3192.
8. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organisation of the basal ganglia. J.Anat. 2000, 196:527-542.
9. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. Post-receptor mechanisms underlying striatal long-term depression. J.Neurosci. 1994, 14:4871-4881.
10. Calabresi P., Saiardi A., Pisani A., Baik J.H., Centonze D., Mercuri N.B., Bernardi G., Borrelli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J.Neurosci. 1997, 17:4536-4544.
11. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J.Neurosci. 1999, 19:3248-3257.
12. Chavis P., Fagni L., Lansman J.B., Bockaert J. Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature 1996, 382:719-722.
13. Choi S., Lovinger D.M. Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc. Natl. Acad. Sci. USA 1997, 94:2665-2670.
14. DeLong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch. Neurol. 2007, 64:20-24.
15. Ding J., Guzman J.N., Tkatch T., Chen S., Goldberg J.A., Ebert P.J., Levitt P., Wilson C.J., Hamm H.E., Surmeier D.J. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat. Neurosci. 2006, 9:832-842.
16. Filion M., Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 1991, 547:142-151.
17. Fino E., Paille V., Cui Y., Morera-Herreras T., Deniau J.M., Venance L. Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity. J.Physiol. 2010, 588:3045-3062.
18. Fleming S.M., Salcedo J., Fernagut P.O., Rockenstein E., Masliah E., Levine M.S., Chesselet M.F. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J.Neurosci. 2004, 24:9434-9440.
19. Fuxe K., Ferré S., Canals M., Torvinen M., Terasmaa A., Marcellino D., Goldberg S.R., Staines W., Jacobsen K.X., Lluis C., et al. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J.Mol. Neurosci. 2005, 26:209-220.
20. Fuxe K., Marcellino D., Genedani S., Agnati L. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. Mov. Disord. 2007, 22:1990-2017.
21. Gao Y., Vasilyev D.V., Goncalves M.B., Howell F.V., Hobbs C., Reisenberg M., Shen R., Zhang M.Y., Strassle B.W., Lu P., et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J.Neurosci. 2010, 30:2017-2024.
22. Geurts M., Maloteaux J.M., Hermans E. Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. Biochem. Pharmacol. 2003, 66:1163-1170.
23. Giuffrida A., Parsons L.H., Kerr T.M., Rodríguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 1999, 2:358-363.
24. Gold S.J., Ni Y.G., Dohlman H.G., Nestler E.J. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J.Neurosci. 1997, 17:8024-8037.
25. Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science 1994, 265:1826-1831.
26. Hashimotodani Y., Ohno-Shosaku T., Tsubokawa H., Ogata H., Emoto K., Maejima T., Araishi K., Shin H.S., Kano M. Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45:257-268.
27. Henkels K.M., Peng H.J., Frondorf K., Gomez-Cambronero J. Acomprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation. Mol. Cell. Biol. 2010, 30:2251-2263.
28. Hikosaka O., Takikawa Y., Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol. Rev. 2000, 80:953-978.
29. Huang J., Zhou H., Mahavadi S., Sriwai W., Murthy K.S. Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2. Am. J. Physiol. Cell Physiol. 2007, 292:C200-C208.
30. Hubbard K.B., Hepler J.R. Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. Cell. Signal. 2006, 18:135-150.
31. Jung K.M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M., Mackie K., Piomelli D. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 2005, 68:1196-1202.
32. Kheirbek M.A., Britt J.P., Beeler J.A., Ishikawa Y., McGehee D.S., Zhuang X. Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J.Neurosci. 2009, 29:12115-12124.
33. Kitada T., Pisani A., Porter D.R., Yamaguchi H., Tscherter A., Martella G., Bonsi P., Zhang C., Pothos E.N., Shen J. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl. Acad. Sci. USA 2007, 104:11441-11446.
34. Kitada T., Pisani A., Karouani M., Haburcak M., Martella G., Tscherter A., Platania P., Wu B., Pothos E.N., Shen J. Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice. J.Neurochem. 2009, 110:613-621.
35. Kreitzer A.C., Malenka R.C. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J.Neurosci. 2005, 25:10537-10545.
36. Kreitzer A.C., Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
37. Kreitzer A.C., Malenka R.C. Striatal plasticity and basal ganglia circuit function. Neuron 2008, 60:543-554.
38. Kuhn A., Goldstein D.R., Hodges A., Strand A.D., Sengstag T., Kooperberg C., Becanovic K., Pouladi M.A., Sathasivam K., Cha J.H., et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet. 2007, 16:1845-1861.
39. Kurz A., Double K.L., Lastres-Becker I., Tozzi A., Tantucci M., Bockhart V., Bonin M., García-Arencibia M., Nuber S., Schlaudraff F., et al. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS ONE 2010, 5:e11464.
40. Lerner T.N., Horne E.A., Stella N., Kreitzer A.C. Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists. J.Neurosci. 2010, 30:2160-2164.
41. Lerner T.N., Kreitzer A.C. Neuromodulatory control of striatal plasticity and behavior. Curr. Opin. Neurobiol. 2011, 21:322-327.
42. Leung D., Saghatelian A., Simon G.M., Cravatt B.F. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 2006, 45:4720-4726.
43. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Macias R., Alvarez L., Guridi J., Vitek J., DeLong M.R. Pathophysiologic basis of surgery for Parkinson's disease. Neurology 2000, 55(12, Suppl 6):S7-S12.
44. Packard M.G., Knowlton B.J. Learning and memory functions of the Basal Ganglia. Annu. Rev. Neurosci. 2002, 25:563-593.
45. Peterson D.A., Sejnowski T.J., Poizner H. Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol. Dis. 2010, 37:558-573.
46. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4:873-884.
47. Ronesi J., Lovinger D.M. Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J.Physiol. 2005, 562:245-256.
48. Saugstad J.A., Marino M.J., Folk J.A., Hepler J.R., Conn P.J. RGS4 inhibits signaling by group I metabotropic glutamate receptors. J.Neurosci. 1998, 18:905-913.
49. Schwendt M., McGinty J.F. Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine behavioral sensitization. J.Pharmacol. Exp. Ther. 2007, 323:650-657.
50. Schwendt M., Hearing M.C., See R.E., McGinty J.F. Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum. Neuroreport 2007, 18:1261-1265.
51. Shen W., Flajolet M., Greengard P., Surmeier D.J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008, 321:848-851.
52. Sung K.W., Choi S., Lovinger D.M. Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J.Neurophysiol. 2001, 86:2405-2412.
53. Surmeier D.J., Plotkin J., Shen W. Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection. Curr. Opin. Neurobiol. 2009, 19:621-628.
54. Tanimura A., Yamazaki M., Hashimotodani Y., Uchigashima M., Kawata S., Abe M., Kita Y., Hashimoto K., Shimizu T., Watanabe M., et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 2010, 65:320-327.
55. Taylor S.J., Chae H.Z., Rhee S.G., Exton J.H. Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature 1991, 350:516-518.
56. Taymans J.M., Kia H.K., Claes R., Cruz C., Leysen J., Langlois X. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. Eur. J. Neurosci. 2004, 19:2249-2260.
57. Tozzi A., Tscherter A., Belcastro V., Tantucci M., Costa C., Picconi B., Centonze D., Calabresi P., Borsini F. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Neuropharmacology 2007, 53:783-789.
58. 2A receptor interaction in the striatum: implications for Parkinson's disease. J.Neurosci. 2011, 31:1850-1862.
59. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J.Neurosci. 2007, 27:3663-3676.
60. Wang Z., Kai L., Day M., Ronesi J., Yin H.H., Ding J., Tkatch T., Lovinger D.M., Surmeier D.J. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 2006, 50:443-452.
61. Yin H.H., Knowlton B.J. The role of the basal ganglia in habit formation. Nat. Rev. Neurosci. 2006, 7:464-476.
62. Yin H.H., Lovinger D.M. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl. Acad. Sci. USA 2006, 103:8251-8256.
63. Zhang Y., James M., Middleton F.A., Davis R.L. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2005, 137B:5-16.